Jacob Thaysen is the new CEO of Illumina
Illumina's board has appointed Jacob Thaysen as the new CEO of the DNA sequencing company. Thaysen, a 48-year-old executive with a long history at the medical devices firm Agilent, is set to assume the role of CEO on September 25th. This appointment follows a period of contention involving a proxy...